The Thai Food and Drug Administration (FDA) has implemented Fast Track measures to address the global crisis and prevent shortages of medicines and health products.

The Thai Food and Drug Administration (FDA) has authorized changes to raw material sources, packaging modifications, and opened a fast-track approval process to ensure that the public has continuous access to essential medicines, food, and health products.

March 23, 2569 Pharmacist Supatra Boonsearm, Secretary-General of the Food and Drug Administration. It has been revealed that the conflict in the Middle East has affected international logistics and supply chains, particularly the import of raw materials and packaging used in the production of health products, which may cause delays and shortages.

And with rising costs, to prevent the public from being affected in accessing essential health products, the Food and Drug Administration (FDA) has implemented measures to facilitate businesses in order to mitigate the impact on access to essential health products from the crisis in the Middle East, helping businesses to adapt appropriately during the crisis.

Maintaining high standards of quality, safety, and effectiveness of health products is paramount, while also ensuring that there are no shortages in the country. Key measures include:

• Changing the source of raw materials. Businesses are permitted to change the source of raw materials, solvents, or the form of raw materials, provided that this does not affect the chemical structure, quality, safety, and efficacy of the approved product.
• Modification of packaging In the event of a shortage, the packaging type, style, or size can be changed, provided that it meets or exceeds the original standards and safety requirements.
• Open a fast-track review process. To expedite the approval of various modifications, in response to emergencies, and to minimize the impact on production and distribution in the system.

Businesses can find more details about the criteria and application procedures on the FDA website at: https://www.fda.moph.go.th/

Secretary-General of the FDA Repeatedly said The main objective of these measures is to “maintain the continuity of public access to health products,” including medicines, food, medical devices, and other essential health products. The FDA will closely monitor the situation and is ready to adjust additional measures as needed to ensure that the public can be confident that health products remain sufficient, safe, and meet standards.

refer : oryor.com

Read related news

• The Ministry of Public Health reveals that domestic drug reserves are sufficient for 3 months. If the crisis is prolonged, herbal medicines can be used as an alternative.
• The Ministry of Public Health confirms Thailand has sufficient drug stockpiles for several more months and is urgently coordinating with private hospitals to maintain the stability of the drug supply system.